【レポートの概要(一部)】
1. Report Overview
1.1 Overview of the World Market for Those Medicines
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to Anti-Cancer Kinase Inhibitors
2.1 What are Protein Kinases?
2.2 Protein Kinases in Oncology
2.3 Mechanisms for Kinase Inhibition
2.4 Glossary of Terms
3. Anti-Cancer Kinase Inhibitors: World Market 2014-2024
3.1 The Global Market for Anti-Cancer Kinase Inhibitors in 2013
3.1.1 Leading Anti-Cancer Kinase Inhibitors by Sales, 2013
3.1.2 Leading Companies in the Protein Kinase Inhibitor Market
3.2 World Protein Kinase Inhibitors for Oncology Market: Sales Forecast by Class, 2014-2024
3.2.1 Changing Market Shares by Segment 2014-2024
3.2.2 Leading Anti-Cancer Kinase Inhibitors Manufacturers, 2014-2024
3.3 Bcr-Abl Inhibitors Lead the Protein Kinase Inhibitors for Oncology Market in 2013
3.3.1 Bcr-Abl Kinase Inhibitors: Drivers and Restraints 2014-2024
3.4 Imbruvica and Other Novel Kinase Inhibitors Will Eventually Dominate the Market
3.4.1 Other Kinase Inhibitors: Drivers and Restraints, 2014-2024
4. Leading National and Regional Markets, 2014-2024
4.1 Regional Breakdown of the World Protein Kinase Inhibitors for Drugs Treating Cancer
4.2 World Protein Kinase Inhibitors for Oncology Market: Regional Forecast 2014-2024
4.2.1 How Will Regional Market Shares Change Through to 2024?
4.3 The US Anti-Cancer Kinase Inhibitor Market Forecast, 2014-2024
4.4 The US Market: Drivers and Restraints, 2014-2024
4.5 The EU Union Anti-Cancer Kinase Inhibitors Market Forecast, 2014-2024
4.5.1 EU Market: Drivers and Restraints
4.5.2 German Market Forecast, 2014-2024
4.5.3 French Market Forecast, 2014-2024
4.5.4 Italian Market Forecast, 2014-2024
4.5.5 UK Market Forecast, 2014-2024
4.5.6 Spanish Market Forecast, 2014-2024
4.6 The Japanese Anti-Cancer Kinase Inhibitor Market Forecast, 2014-2024
4.7 Forecasting Anti-Cancer Kinase Inhibitor Markets in Developing Countries, 2014-2024
4.7.1 Chinese Market Forecast, 2014-2024
4.7.2 Brazilian Market Forecast, 2014-2024
4.7.3 Russian Market Forecast, 2014-2024
4.7.4 Indian Market Forecast, 2014-2024
5. Leading Anti-Cancer Kinase Inhibitors Products, 2014-2024
5.1 Brc-Abl Inhibitors – Managed Care for Chronic Myeloid Leukaemia
5.1.1 Gleevec (imatinib) – Novartis
5.1.1.1 Historic Sales Performance
5.1.1.2 Lifecycle Management, Generic Challenges and Tasigna
5.1.1.3 Gleevec Forecast, 2014-2024
5.1.2 Sprycel (dasatanib) – Bristol-Myers Squibb
5.1.2.1 Patents and Market Exclusivity
5.1.2.2 Historic Sales Performance
5.1.2.3 Sprycel Forecast, 2014-2024
5.1.3 Tasigna (nilotinib) – Novartis
5.1.3.1 Indications and Market Exclusivity
5.1.3.2 Historic Sales Performance
5.1.3.3 Tasigna Forecast, 2014-2024
5.1.4 Bosulif (bosutinib) – Pfizer
5.1.4.1 Bosulif Forecast, 2014-2024
5.1.5 Iclusig (ponatinib) – ARIAD Pharmaceuticals
5.1.5.1 Iclusig Forecast, 2014-2024
5.2 EGFR Inhibitors
5.2.1 Tarceva (erlotinib) – Roche/Astellas
5.2.1.1 Patent Litigation and Market Exclusivity
5.2.1.2 Historic Sales Performance, 2004-2012
5.2.1.3 Tarceva Forecast, 2014-2024
5.2.2 Iressa (gefitinib) – AstraZeneca
5.2.2.1 Historic Sales Performance, 2003-2012
5.2.2.2 Iressa Forecast, 2014-2024
5.2.3 Gilotrif (afatinib) – Boehringer Ingelheim
5.2.3.1 Gilotrif Forecast, 2014-2024
5.3 Angiogenesis Inhibitors
5.3.1 Nexavar (sorafenib) – Bayer/Onyx
5.3.1.1 Historic Sales Performance, 2006-2012
5.3.1.2 Nexavar Forecast, 2014-2024
5.3.2 Sutent (sunitinib) – Pfizer
5.3.2.1 Historic Sales Performance, 2006-2012
5.3.2.2 Sutent Forecast, 2014-2024
5.3.3 Votrient (pazopanib) – GSK
5.3.3.1 Historic Sales Performance, 2010-2012
5.3.3.2 Votrient Forecast, 2014-2024
5.3.4 Inlyta (axitinib) – Pfizer
5.3.4.1 Inlyta Forecast, 2014-2024
5.4 BRAF and MEK Inhibitors
5.4.1 Zelboraf (vemurafenib) – Roche/Daiichi Sankyo
5.4.1.1 Zelboraf Forecast, 2014-2024
5.4.2 Mekinist (trametinib) and Tafinlar (dabrafenib) – GSK
5.4.2.1 Mekinist Forecast, 2014-2024
5.4.2.2 Tafinlar Forecast, 2014-2024
5.5 mTOR Inhibitors
5.5.1 Afinitor (everolimus) – Novartis
5.5.1.1 Patents and Market Exclusivity
5.5.1.2 Historic Sales Performance
5.5.1.3 Afinitor Forecast, 2014-2024
5.5.2 Torisel (temsirolimus) – Pfizer
5.5.2.1 Torisel Forecast, 2014-2024
5.6 Other leading Anticancer Kinase Inhibitors
5.6.1 Imbruvica (ibrutinib) –J&J/Pharmacyclics
5.6.1.1 Imbruvica Forecast, 2014-2024
5.6.2 Jakafi (ruxolitinib) – Novartis/Incyte
5.6.2.1 Jakafi Forecast, 2014-2024
5.6.3 Xalkori (crizotinib) – Pfizer
5.6.3.1 Xalkori Forecast, 2014-2024
5.6.4 Cometriq (cabozantinib) – Exelixis
5.6.4.1 Cometriq Forecast, 2014-2024
5.6.5 Caprelsa (vandetanib) – AstraZeneca
5.6.5.1 Caprelsa Forecast, 2014-2024
5.6.6 Tykerb (lapatinib) – GSK
5.6.6.1 Historic Sales Performance, 2007-2012
5.6.6.2 Tykerb Forecast, 2014-2024
5.6.7 Stivarga (regorafenib) – Bayer
5.6.7.1 Stivarga Forecast, 2014-2024
6. Anti-Cancer Kinase Inhibitors: R&D Pipeline, 2014-2024
6.1 Cyclin-Dependent Kinase 4/6 Inhibitors in Development
6.1.1 Palbociclib – Pfizer
6.1.1.1 Palbociclib Forecast, 2014-2024
6.1.2 LEE-011 – Novartis
6.1.2.1 LEE-011 Forecast, 2014-2024
6.1.3 Bemaciclib (LY2835219) – Eli Lilly
6.1.3.1 Bemaciclib Forecast, 2014-2024
6.2 Anaplastic Lymphoma Kinase (ALK) Inhibitors In Development
6.2.1 Alectinib – Roche
6.2.1.1 Alectinib Forecast, 2014-2024
6.2.2 Ceritinib (LDK378) – Novartis
6.2.2.1 Ceritinib Forecast, 2014-2024
6.2.3 AP26113 – ARIAD
6.3 Bruton’s Tyrosine Kinase and PI3K Inhibitors in Development
6.3.1 Idelalisib – Gilead
6.3.1.1 Idelalisib Forecast, 2014-2024
6.3.2 RG7601 (ABT-199) – Roche/AbbVie
6.3.2.1 ABT-199 Sales Forecast, 2014-2024
6.3.3 IPI-145 – Infinity Pharmaceuticals
6.3.3.1 IPI-145 Forecast, 2014-2024
6.3.4 Buparlisib (BKM120) – Novartis
6.3.4.1 Buparlisib Forecast, 2014-2024
6.3.5 ONO-4059 – Ono Pharmaceuticals
6.3.6 Copanlisib (BAY 80-6946) – Bayer
6.3.7 Pictilisib (GDC-0941) – Roche
6.3.8 BEZ235 – Novartis
6.4 MEK and BRAF Inhibitors in Development
6.4.1 Cobimetinib (GDC-0973) – Roche
6.4.1.1 Cobimetinib Forecast, 2014-2024
6.4.2 Encorafenib (LGX818) – Novartis
6.4.3 Binimetinib (MEK162) – Novartis
6.4.4 Selumetinib (AZD 6244) – AstraZeneca
6.5 Other Kinase Inhibitors in Development
6.5.1 Volasertib – Boehringer Ingelheim
6.5.1.1 Volasertib Forecast, 2014-2024
6.5.2 Neratinib (PB272) – Puma Biotechnology
6.5.3 Tivantinib (ARQ197) – Daiichi Sankyo
6.5.4 Dovotinib (TKI258) – Novartis
6.5.5 Dacomitinib – Pfizer
6.5.6 CO-1686 – Clovis Oncology
7. Qualitative Analysis of the Anti-Cancer Kinase Inhibitor Market, 2014-2024
7.1 SWOT Analysis of the Protein Kinase Inhibitors for Oncology Market
7.2 Strengths
7.2.1 Oral Dosage Preferred Over Injection
7.2.2 Stratifying Patients Offers Clinical and Commercial Benefits
7.2.3 Targeted Kinase Inhibitor are Generally Well Tolerated
7.2.4 A Strong Pipeline of Novel Inhibitors Will Drive Market Growth
7.3 Weaknesses
7.3.1 Small Molecule Kinase Inhibitors Will Experience Generic Competition
7.3.2 Competitor Biologics Offer Differentiated Mechanisms of Action
7.3.3 Monoclonal Antibodies are More Specific than Small Molecules
7.4 Opportunities
7.4.1 Novel Targets Identified Through Cancer Genomics
7.4.2 Combination Therapies Bring Additive Benefits
7.4.3 Commercial Success Leveraged by Clinical Benefit
7.5 Threats
7.5.1 Small Molecules Generics Are Easy to Produce
7.5.2 Individual Kinase Targets are Rapidly Becoming Crowded
7.6 STEP Analysis of the Protein Kinase Inhibitors for Oncology Market
7.7 Porter’s Five Forces Analysis of the Anti-Cancer Kinase Inhibitor Market, 2014-2024
7.7.1 Rivalry Among Competitors
7.7.2 Threat of New Entrants
7.7.3 Power of Suppliers
7.7.4 Power of Buyers
7.7.5 Threat of Substitutes
8. Research Interview
8.1 Interview with Dr Lawrence Bloch, Chief Finance and Business Officer, Infinity Pharmaceuticals, United States
8.1.1 Positioning a Novel Therapeutic in Blood Cancer Indications
8.1.2 Combining Therapies Offers Significant Benefit to Patients
8.1.3 Potential in Rheumatoid Arthritis and Blood Cancers
9. Conclusions
9.1 The Global Anti-Cancer Kinase Inhibitors Market to 2024
9.1.1 A Robust Pipeline of Innovative Drugs Driving Market Growth
9.2 Leading National Markets for Anti-Cancer Kinase Inhibitors to 2024
【レポート販売概要】
■ タイトル:世界の癌治療用キナーゼ阻害剤市場:Brc-Abl阻害剤/EGFR阻害剤/血管新生阻害剤/BRAF・MEK阻害剤/mTOR阻害剤など■ 英文:Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024
■ 発行日:2014年6月
■ 調査会社:visiongain
■ 商品コード:VISG409052
■ 調査対象地域:グローバル
- バッテリー式電気自動車(BEV)の世界市場:主要企業動向、販売予測、充電ステーションインフラ予測The latest report from business intelligence provider visiongain offers comprehensive analysis of the global Battery Electric Vehicle (BEV) market. Visiongaain assesses that the BEV market will generate revenues of $46.3bn in 2015. Now: "Consumers have largely shunned electric vehicles because of their high price tags and limited driving range, as well as the scarcity of charging stations, though …
- 世界の鉛蓄電池市場動向(2014-2018)TechNavio's analysts forecast the Global Lead Acid Battery market to grow at a CAGR of 3.5 percent over the period 2013-2018. One of the key factors contributing to this market growth is the development of AGM lead-acid batteries. The Global Lead Acid Battery market has also been witnessing an increase in the power deficit. However, the possibility of explosion could pose a challenge to the growth …
- ゼロカロリー甘味料の世界市場2017-2021ABSTRACTAbout Zero-Calorie Sweetener Consumers are purchasing products that have low sugar and calorie content to maintain a suitable body weight and avoid health problems such as obesity, high/low blood pressure, and tooth decay. Sweeteners are now becoming common in homes across the globe, appearing in many “sugar-free” or “diet” candies, cookies, and beverages. Players are thus using sweeteners …
- 界面活性剤の世界市場:陰イオン界面活性剤、陽イオン界面活性剤、非イオン界面活性剤、両性界面活性剤About Surfactants Surface active agents are popularly known as surfactants. Surfactants are materials that can significantly reduce the surface tension between two liquids or between a solid and a liquid. They display hydrophilic and lipophilic properties. Foaming, detergency, dispersion, penetration, and wetting effect are the important characteristics of surfactants. Based on their application, …
- ストレージ・ソフトウェアのグローバル市場動向(2014-2018)About Storage Software Storage software is an effective tool used by enterprises to improve the control and management of storage hardware devices and networks. Storage software comprises all software products that are used for efficient data management and data storage in the enterprise infrastructure. Storage software can be used for device management, data transmission, data security, data reco …
- 肥料添加物の世界市場分析:機能別(腐食防止剤、疎水剤、防塵剤、固結防止剤)、最終製品別(尿素、硝酸アンモニウム、リン酸アンモニウム、硫酸アンモニウム)、セグメント予測The global fertilizer additives market is projected to reach USD 3.94 billion by 2024, according to a new report by Grand View Research, Inc. Growing fertilizer industry and shrinking arable land are projected to drive the market over the forecast period. Additives are added to fertilizers in order to inhibit the loss of key nutrients such as nitrogen phosphorus, potassium, and sulfur, among other …
- グローバルにおける包装機械市場(2014-2018)About Packaging Machinery Packaging machineries are the special types of machineries that provide assistance for packaging the products before its being dispatch for storage and distribution networks. Packaging is being increasingly considered an important part of marketing mix as packaging created a strong impact on the customers buying decision. Packaging machinery is widely used for filling, la …
- 配電線路用電圧レギュレータの世界市場:タップ切換式/鉄共振式電圧レギュレータThe global distribution voltage regulator market is projected to grow from $1,997.5 million to $2,482.5 million at a CAGR of from 4.7% 2014 to 2019. Asia-Pacific was the single-largest market for distribution voltage regulators in 2013, holding 43.5% share, and is set to continue its dominance till 2019. The Middle East and Africa is projected to emerge as the fastest growing market during the for …
- 水溶性肥料の世界市場2019-2023About this market Increase in demand from developing countries will drive the growth of the water soluble fertilizers market. The growth of agriculture to meet the growing food requirement have contributed to the market growth. The growing demand for high quality fertilizers coupled with technology driven irrigation in countries like China India, Brazil are expected to drive the demand for water s …
- 世界の無線LANホットスポット市場動向(2012-2016)TechNavio's analysts forecast the Global Wi-Fi Hotspot market to grow at a CAGR of 0.84 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased use of mobile devices. The Global Wi-Fi Hotspot market has also been witnessing increased adoption of Wi-Fi services in smart homes. However, security issues associated with the use of wireless networks …
- 室内空気品質(IAQ)の世界市場2016-2020About Indoor Air Quality The quality of indoor air is decided based on the amount of pollutants, humidity, and temperature. Maintaining it is important because the poor quality of air can negatively impact the health, performance, productivity, and well-being (both physical and mental) of the occupants. Breathing stuffy, stale, or even damp air can cause discomfort, illness, and even trigger behav …
- シーフード加工機器の世界市場:シーフード種類別(フィンフィッシュ、甲殻類、軟体動物、その他)、機器の種類別(ガッティング、スケーリング、スキニング、脱骨、切り身、その他)Seafood is perceived as an excellent source of high-quality protein holding lipids, high levels of unsaturated fatty acids, and possibly augments human health by reducing the risk of cardiovascular disease. There are numerous species of seafoods falling primarily under the category of four types, namely finfish, crustaceans, mollusks, and others. The equipment required to process different types o …
- 燃料電池市場予測(~2015年)Fuel Cell Market Forecast to 2015Over the past few years, the global fuel cell industry has been growing at a rapid pace. Fuel cell is emerging as the best source of green energy and is expected to change the energy consumption scenario in the coming years. The fuel cell technology has been gaining rapid acceptance backed by various advantages over other green energy sources. Constant government support, regulations like amendmen …
- 有機顔料の世界市場2017-2021: アゾ顔料、フタロシアニン顔料、その他有機顔料About Organic Pigment Pigments are soluble colorants that are usually in the powder form. Pigments are derived from minerals. They can be produced synthetically as well. Pigments offer enormous options in terms of color. They have better color retention properties in comparison with dyes. Pigments add value in terms of visual appeal and durability to various products such as textiles, food product …
- Chugach Electric Association, Inc.:発電所及びSWOT分析2013Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - …